© 2026 NervNow™. All rights reserved.
Senhwa Biosciences Signs Up to $16M Deal to Advance AI Drug Discovery

The agreement provides flexible access to capital to support the company’s expansion into AI drug discovery, particularly in oncology-focused research pipelines.













